Recent articles

Mark Poznansky, M.D., Ph.D., wants the seemingly impossible—a person with type 1 diabetes (T1D) has a procedure where beta cells are placed in their body, the doctor stitches it up and the person has functioning insulin-producing beta cells, for life. Of course, we’re not there yet, but, with Dr. Poznansky—and many, many other researchers—Breakthrough T1D […]

Dr. Carla Greenbaum

Carla Greenbaum, M.D., chair of TrialNet—an international Breakthrough T1D-supported network that is dedicated to finding cures for type 1 diabetes (T1D)—and a professor at Benaroya Research Institute, discussed T1D research in the time of COVID-19, including what TrialNet is up to, on Breakthrough T1D’s Facebook Live event. She chats about: What do we know now […]

T1D Type 1 Diabetes Consortium

It was 2015—five years ago—that three organizations (BreakthroughT1D, the Endocrine Society and the American Diabetes Association) published a statement urging the adoption of a staging system of type 1 diabetes (T1D) that uses islet autoantibodies as biomarkers. (Biomarkers, in this sense, are indicators that a person is developing T1D but is still without symptoms.) It […]

TrialNet—an international Breakthrough T1D-supported network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams dedicated to finding cures for type 1 diabetes (T1D)—has a new in-home test kit that makes screening far more easy and convenient. And FedEx will come pick it up, at no cost to you! If you have a relative with […]

Breakthrough T1D partners with Carb DM to make event a reality A long-running California type 1 diabetes (T1D) event can now be attended by anyone, anywhere in the world. The Bay Area Diabetes Summit on April 26 brings together some of the most renowned experts in T1D to discuss T1D research, psycho-social challenges and technology […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the Latest T1D Updates

Sign up for our monthly mission progress newsletter, The Pipeline, to stay up to date on everything you need to know about T1D, from research to advocacy, to clinical care – and everything in between.

  • This field is for validation purposes and should be left unchanged.